Response of elephant peripheral blood mononuclear cells when stimulated with elephant endotheliotropic herpesvirus glycoprotein B (EEHV-gB).

[1]  C. D. de Haan,et al.  EEHV1A glycoprotein B subunit vaccine elicits humoral and cell-mediated immune responses in mice. , 2022, Vaccine.

[2]  W. Hsu,et al.  Development of Nonstructural Protein-Based Indirect ELISA to Identify Elephant Endotheliotropic Herpesvirus (EEHV) Infection in Asian Elephants (Elephas maximus) , 2022, Animals : an open access journal from MDPI.

[3]  P. Ling,et al.  Modified vaccinia Ankara expressing EEHV1A glycoprotein B elicits humoral and cell-mediated immune responses in mice , 2022, PloS one.

[4]  W. Kasinrerk,et al.  Very low concentration of lipopolysaccharide can induce the production of various cytokines and chemokines in human primary monocytes , 2022, BMC research notes.

[5]  H. Doddapaneni,et al.  Primary Infection May Be an Underlying Factor Contributing to Lethal Hemorrhagic Disease Caused by Elephant Endotheliotropic Herpesvirus 3 in African Elephants (Loxodonta africana) , 2021, Microbiology spectrum.

[6]  Jiajia Tang,et al.  Cell Fusion and Syncytium Formation in Betaherpesvirus Infection , 2021, Viruses.

[7]  C. Thitaram,et al.  Pathogenesis of hemorrhagic disease caused by elephant endotheliotropic herpesvirus (EEHV) in Asian elephants (Elephas maximus) , 2021, Scientific Reports.

[8]  Shahin Nazarian,et al.  An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study , 2020, Scientific Reports.

[9]  Janine L. Brown,et al.  Successful treatment of elephant endotheliotropic herpesvirus infection in an Asian elephant (Elephas maximus) calf by oral acyclovir medication: Case report , 2020, The Journal of veterinary medical science.

[10]  W. Hsu,et al.  In vivo characterization of target cells for acute elephant endotheliotropic herpesvirus (EEHV) infection in Asian elephants (Elephas maximus) , 2020, Scientific Reports.

[11]  G. Hayward,et al.  Lethal Hemorrhagic Disease and Clinical Illness Associated with Elephant Endotheliotropic Herpesvirus 1 Are Caused by Primary Infection: Implications for the Detection of Diagnostic Proteins , 2019, Journal of Virology.

[12]  V. Punyapornwithaya,et al.  Possible roles of monocytes/macrophages in response to elephant endotheliotropic herpesvirus (EEHV) infections in Asian elephants (Elephas maximus) , 2019, PloS one.

[13]  V. Punyapornwithaya,et al.  Survival analysis of confirmed elephant endotheliotropic herpes virus cases in Thailand from 2006 – 2018 , 2019, PloS one.

[14]  C. S. Nelson,et al.  HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions , 2018, Proceedings of the National Academy of Sciences.

[15]  C. Thitaram,et al.  Production of antibody against elephant endotheliotropic herpesvirus (EEHV) unveils tissue tropisms and routes of viral transmission in EEHV-infected Asian elephants , 2018, Scientific Reports.

[16]  P. Griffiths,et al.  Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From Viremia , 2018, The Journal of infectious diseases.

[17]  A. Leen,et al.  Asian Elephant T Cell Responses to Elephant Endotheliotropic Herpesvirus , 2017, Journal of Virology.

[18]  S. Sripiboon,et al.  SUCCESSFUL TREATMENT OF A CLINICAL ELEPHANT ENDOTHELIOTROPIC HERPESVIRUS INFECTION: THE DYNAMICS OF VIRAL LOAD, GENOTYPE ANALYSIS, AND TREATMENT WITH ACYCLOVIR , 2017, Journal of Zoo and Wildlife Medicine.

[19]  J. H. Amorim,et al.  In silico design of a Zika virus non-structural protein 5 aiming vaccine protection against zika and dengue in different human populations , 2017, Journal of Biomedical Science.

[20]  Rasel Das,et al.  In silico-based vaccine design against Ebola virus glycoprotein , 2017, Advances and applications in bioinformatics and chemistry : AABC.

[21]  K. Worley,et al.  Complete Genome Sequence of Elephant Endotheliotropic Herpesvirus 4, the First Example of a GC-Rich Branch Proboscivirus , 2016, mSphere.

[22]  G. Hayward,et al.  Detection of Quiescent Infections with Multiple Elephant Endotheliotropic Herpesviruses (EEHVs), Including EEHV2, EEHV3, EEHV6, and EEHV7, within Lymphoid Lung Nodules or Lung and Spleen Tissue Samples from Five Asymptomatic Adult African Elephants , 2015, Journal of Virology.

[23]  E. Heldwein,et al.  Herpesvirus gB: A Finely Tuned Fusion Machine , 2015, Viruses.

[24]  E. Heldwein,et al.  Crystal Structure of the Human Cytomegalovirus Glycoprotein B , 2015, PLoS pathogens.

[25]  E. Settembre,et al.  Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody , 2015, Nature Communications.

[26]  A. Duschl,et al.  Residual Endotoxin Contaminations in Recombinant Proteins Are Sufficient to Activate Human CD1c+ Dendritic Cells , 2014, PloS one.

[27]  G. Hayward,et al.  Elephant Endotheliotropic Herpesviruses EEHV1A, EEHV1B, and EEHV2 from Cases of Hemorrhagic Disease Are Highly Diverged from Other Mammalian Herpesviruses and May Form a New Subfamily , 2014, Journal of Virology.

[28]  G. Hayward,et al.  Comparative Genome Analysis of Four Elephant Endotheliotropic Herpesviruses, EEHV3, EEHV4, EEHV5, and EEHV6, from Cases of Hemorrhagic Disease or Viremia , 2014, Journal of Virology.

[29]  Michele A. Miller,et al.  Differences in immune cell function between tuberculosis positive and negative Asian elephants. , 2014, Tuberculosis.

[30]  P. Ling,et al.  DETECTION OF ELEPHANT ENDOTHELIOTROPIC HERPESVIRUS INFECTION AMONG HEALTHY ASIAN ELEPHANTS (ELEPHAS MAXIMUS) IN SOUTH INDIA , 2014, Journal of wildlife diseases.

[31]  Brent J. Ryckman,et al.  Human Cytomegalovirus (HCMV) Glycoprotein gB Promotes Virus Entry In Trans Acting as the Viral Fusion Protein Rather than as a Receptor-Binding Protein , 2013, mBio.

[32]  R. Gibbs,et al.  Complete Genome Sequence of Elephant Endotheliotropic Herpesvirus 1A , 2013, Genome Announcements.

[33]  G. Hayward,et al.  ELEPHANT ENDOTHELIOTROPIC HERPESVIRUS 5, A NEWLY RECOGNIZED ELEPHANT HERPESVIRUS ASSOCIATED WITH CLINICAL AND SUBCLINICAL INFECTIONS IN CAPTIVE ASIAN ELEPHANTS (ELEPHAS MAXIMUS) , 2013, Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians.

[34]  T. Bouts,et al.  Detection of elephant endotheliotropic herpesvirus type 1 in asymptomatic elephants using TaqMan real-time PCR , 2011, Veterinary Record.

[35]  T. Winkler,et al.  B Cell Repertoire Analysis Identifies New Antigenic Domains on Glycoprotein B of Human Cytomegalovirus which Are Target of Neutralizing Antibodies , 2011, PLoS pathogens.

[36]  R. Khanna,et al.  Recombinant glycoprotein B vaccine formulation with Toll-like receptor 9 agonist and immune-stimulating complex induces specific immunity against multiple strains of cytomegalovirus. , 2011, The Journal of general virology.

[37]  T. Jardetzky,et al.  Fusing structure and function: a structural view of the herpesvirus entry machinery , 2011, Nature Reviews Microbiology.

[38]  G. Hayward,et al.  Detection and evaluation of novel herpesviruses in routine and pathological samples from Asian and African elephants: identification of two new probosciviruses (EEHV5 and EEHV6) and two new gammaherpesviruses (EGHV3B and EGHV5). , 2011, Veterinary microbiology.

[39]  G. Hayward,et al.  Detection of pathogenic elephant endotheliotropic herpesvirus in routine trunk washes from healthy adult Asian elephants (Elephas maximus) by use of a real-time quantitative polymerase chain reaction assay. , 2010, American journal of veterinary research.

[40]  M. Jarvis,et al.  A Human Cytomegalovirus gO-Null Mutant Fails To Incorporate gH/gL into the Virion Envelope and Is Unable To Enter Fibroblasts and Epithelial and Endothelial Cells , 2009, Journal of Virology.

[41]  T. Compton,et al.  Human Cytomegalovirus Glycoprotein B Is Required for Virus Entry and Cell-to-Cell Spread but Not for Virion Attachment, Assembly, or Egress , 2009, Journal of Virology.

[42]  Brent J. Ryckman,et al.  Human Cytomegalovirus Glycoproteins gB and gH/gL Mediate Epithelial Cell-Cell Fusion When Expressed either in cis or in trans , 2008, Journal of Virology.

[43]  C. Cobbs,et al.  Platelet-derived growth factor-α receptor activation is required for human cytomegalovirus infection , 2008, Nature.

[44]  G. Jahn,et al.  Cytomegalovirus cell tropism. , 2008, Current topics in microbiology and immunology.

[45]  Brent J. Ryckman,et al.  Characterization of the Human Cytomegalovirus gH/gL/UL128-131 Complex That Mediates Entry into Epithelial and Endothelial Cells , 2007, Journal of Virology.

[46]  Shau-ku Huang,et al.  Endotoxin contamination contributes to the in vitro cytokine-inducing activity of osteopontin preparations. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[47]  T. Compton,et al.  Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[48]  D. Bernstein,et al.  Preconception vaccination with a glycoprotein B (gB) DNA vaccine protects against cytomegalovirus (CMV) transmission in the guinea pig model of congenital CMV infection. , 2003, The Journal of infectious diseases.

[49]  R. Brooks,et al.  Endotoxin contamination of particles produces misleading inflammatory cytokine responses from macrophages in vitro. , 2002, The Journal of bone and joint surgery. British volume.

[50]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[51]  G. West,et al.  USE OF FAMCICLOVIR FOR THE TREATMENT OF ENDOTHELIOTROPHIC HERPESVIRUS INFECTIONS IN ASIAN ELEPHANTS (ELEPHAS MAXIMUS) , 2009, Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians.

[52]  J. Crowther.  ELISA Guidebook, The , 2000 .

[53]  Ha Won Kim,et al.  A standardized gating technique for the generation of flow cytometry data for normal canine and normal feline blood lymphocytes. , 2000, Veterinary immunology and immunopathology.

[54]  R. Sekulovich,et al.  Effects of antigen dose and immunization regimens on antibody responses to a cytomegalovirus glycoprotein B subunit vaccine. , 1999, The Journal of infectious diseases.

[55]  Kathleen A. Boyle,et al.  Engagement of the Cellular Receptor for Glycoprotein B of Human Cytomegalovirus Activates the Interferon-Responsive Pathway , 1999, Molecular and Cellular Biology.

[56]  W. Cox,et al.  A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne). , 1999, The Journal of infectious diseases.

[57]  G. Hayward,et al.  Novel endotheliotropic herpesviruses fatal for Asian and African elephants. , 1999, Science.

[58]  Kathleen A. Boyle,et al.  Receptor-Binding Properties of a Soluble Form of Human Cytomegalovirus Glycoprotein B , 1998, Journal of Virology.

[59]  E. Paoletti,et al.  Preclinical evaluation of an ALVAC (canarypox)--human cytomegalovirus glycoprotein B vaccine candidate. , 1995, Vaccine.

[60]  P. Paz,et al.  Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. , 1993, Virology.

[61]  W. Britt,et al.  Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response , 1990, Journal of virology.